packageGolimumab

golimumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Golimumab is a monoclonal antibody that blocks tumour necrosis factor alpha and is used to treat inflammatory conditions such as rheumatoid and psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It is an approved medicine, authorised in the European Union, and is widely used for these immune-mediated diseases.

Summary written by glm-5.3-flash from Wikidata Q413879 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:golimumab
ATC codes:L04AB06
DrugBank:DB06674
Wikidata:Q413879
molar mass:146943 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown